Developmental pluripotency-associated protein 5 (DPPA5) serves as a crucial element in the orchestration of pluripotency and cellular differentiation. The gene encoding DPPA5 is predominantly active in embryonic cells, signifying its role in the early stages of development. The regulation of DPPA5 is a sophisticated process that hinges upon a network of epigenetic markers and signal transduction pathways. These mechanisms ensure that the precise timing and level of DPPA5 expression are maintained, which is vital for its function in developmental processes. The expression of DPPA5 can be induced by a range of chemicals that interact with cellular machinery, resulting in either the direct stimulation of DPPA5 gene transcription or the modification of the chromatin landscape around the DPPA5 locus to facilitate its transcription.
Compounds such as 5-Azacytidine and Valproic Acid exemplify agents that can alter the epigenetic state of the DPPA5 gene, enabling its expression. 5-Azacytidine, a nucleoside analog of cytidine, can be incorporated into DNA where it acts to inhibit DNA methyltransferases, leading to reduced methylation of DNA. This hypomethylated state often correlates with an increase in gene expression, including that of DPPA5. Conversely, Valproic Acid, a short-chain fatty acid, acts as a histone deacetylase (HDAC) inhibitor, increasing the acetylation levels of histones associated with the DPPA5 gene, thereby promoting a more relaxed chromatin structure conducive to gene transcription. Other molecules, such as Forskolin and Lithium Chloride, induce signaling cascades that culminate in the activation of transcription factors or the modulation of other regulatory proteins that can enhance DPPA5 expression. Forskolin raises intracellular cyclic AMP (cAMP) levels, triggering a cascade that can lead to the activation of protein kinase A (PKA) and subsequent phosphorylation of transcription factors that drive DPPA5 gene transcription. Lithium Chloride exerts its effect by activating the Wnt signaling pathway, which is known to play a role in the regulation of gene expression during development, including genes like DPPA5. Collectively, the interplay between these compounds and cellular processes underscores the complex regulatory networks that govern the expression of pivotal developmental genes such as DPPA5.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This cytidine analog could upregulate DPPA5 expression by integrating into DNA and causing demethylation of the gene's promoter region, thereby allowing transcriptional machinery to access the gene. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid might stimulate DPPA5 expression during embryonic stem cell differentiation by activating retinoic acid receptors that bind to the DPPA5 promoter and enhance transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, Trichostatin A has the potential to upregulate DPPA5 by altering the acetylation status of histones associated with the DPPA5 gene, promoting a more open and transcriptionally active chromatin structure. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid could induce DPPA5 expression by preventing the deacetylation of histones near the DPPA5 gene, thus supporting an active transcriptional environment. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin might increase DPPA5 levels by elevating intracellular cAMP, which in turn activates protein kinase A (PKA) and subsequently may lead to the activation of transcription factors that target the DPPA5 gene. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This green tea polyphenol could stimulate the expression of DPPA5 by inhibiting DNA methyltransferases, resulting in decreased methylation of the DPPA5 gene promoter. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate can induce DPPA5 by inhibiting histone deacetylase, which increases acetylation of histones near the DPPA5 gene locus, thereby facilitating transcriptional activation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol might increase DPPA5 expression by activating sirtuins that deacetylate histones in a manner that promotes transcriptional activation of genes like DPPA5. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
This estrogen could upregulate DPPA5 by engaging estrogen receptors, which then interact with estrogen response elements in the DPPA5 promoter to stimulate gene transcription. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone might induce DPPA5 transcription by binding to glucocorticoid receptors that interact with glucocorticoid response elements in the DPPA5 gene promoter. | ||||||